Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Volume Control in Peritoneal Dialysis Patients: Role of New Dialysis Solutions

Volume Control in Peritoneal Dialysis Patients: Role of New Dialysis Solutions This paper reviews the most recent clinical data on the volume status of long-term peritoneal dialysis (PD) patients. It appears that many PD patients are volume overloaded, associated with a high prevalence of hypertension and left ventricular hypertrophy. In the presence of the poor results in patients with peritoneal ultrafiltration, the introduction of the polyglucose solution, icodextrin, has ameliorated volume control in some of these patients. In a second part of the review, some of the structural and functional alterations in the peritoneal membrane and the role of glucose degradation products (GDP) in the commonly used dialysates as well as the resulting formation of advanced glycation end products are described. The introduction of low GDP-containing solutions at normal pH has at least in experimental models of PD attenuated the hemodynamic changes observed with the classical solutions. The solutions at normal pH containing either bicarbonate or a mixture of bicarbonate/lactate were clinically associated with less inflow pain. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Blood Purification Karger

Volume Control in Peritoneal Dialysis Patients: Role of New Dialysis Solutions

Blood Purification , Volume 22 (1): 11 – Jul 1, 2004

Loading next page...
 
/lp/karger/volume-control-in-peritoneal-dialysis-patients-role-of-new-dialysis-k5pe8rpNaT

References (110)

Publisher
Karger
Copyright
© 2004 S. Karger AG, Basel
ISSN
0253-5068
eISSN
1421-9735
DOI
10.1159/000074923
Publisher site
See Article on Publisher Site

Abstract

This paper reviews the most recent clinical data on the volume status of long-term peritoneal dialysis (PD) patients. It appears that many PD patients are volume overloaded, associated with a high prevalence of hypertension and left ventricular hypertrophy. In the presence of the poor results in patients with peritoneal ultrafiltration, the introduction of the polyglucose solution, icodextrin, has ameliorated volume control in some of these patients. In a second part of the review, some of the structural and functional alterations in the peritoneal membrane and the role of glucose degradation products (GDP) in the commonly used dialysates as well as the resulting formation of advanced glycation end products are described. The introduction of low GDP-containing solutions at normal pH has at least in experimental models of PD attenuated the hemodynamic changes observed with the classical solutions. The solutions at normal pH containing either bicarbonate or a mixture of bicarbonate/lactate were clinically associated with less inflow pain.

Journal

Blood PurificationKarger

Published: Jul 1, 2004

Keywords: Volume control; Ultrafiltration failure; Biocompatibility; Glucose degradation products; Left ventricular hypertrophy; Peritoneal dialysis

There are no references for this article.